Parkinson's disease is the second most prevalent neurodegenerative disorder worldwide.
Clinically, it is characterized by severe motor complications caused by progressive …

Introduction: The available therapeutic strategies for Parkinson's disease (PD) rely only on
the amelioration of the symptomatology of the disease, lacking neuroprotection or …

Parkinson's disease (PD) is a progressive neurodegenerative movement disorder that
results from the death of dopamine (DA) neurons. Over recent years, differentiated or …

Mesenchymal stem cell (MSC)-derived secretome demonstrated therapeutic effects like
those reported after MSCs transplantation. MSC-derived secretome may avoid various side …

Parkinson's disease (PD) is characterized by a selective loss of dopamine (DA) neurons in
the human midbrain causing motor dysfunctions. The exact mechanism behind …

Parkinson's disease (PD) is the most common movement disorder, characterized by the
progressive loss of dopaminergic neurons from the nigrostriatal system. Currently, there is …

Background: Cell transplantation to replace lost neurons in neurodegenerative diseases
such as Parkinson's disease (PD) offers a hopeful prospect for many patients. Previously …

Parkinson's disease (PD) is one of the most common neurodegenerative diseases caused
by specific degeneration and loss of dopamine neurons in substantia nigra of the midbrain …

Parkinson's disease (PD) is a neurodegenerative disorder characterized by the
degeneration of dopaminergic neurons and/or loss od neuronal projections, in several …

Human mesenchymal stem cells (hMSCs) secretome has been have been at the forefront of
a new wave of possible therapeutic strategies for central nervous system neurodegenerative …